On June 26th, Gelonhui reported that an investor asked Chunning Biotech (301301.SZ) on the interactive platform whether the company had plans to research weight loss drugs using synthetic biology. The company replied that it currently has no plans to research weight loss drugs. In the field of synthetic biology, the company focuses on health product materials, biopesticides, high value-added natural products, and high-end cosmetic raw materials sectors. It has already launched products such as red yeast alcohol and 5-hydroxytryptophan.
川宁生物(301301.SZ)：暂未有研究减肥药的计划
Chuanning Biological (301301.SZ): Currently, there are no plans to research weight-loss drugs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.